141 related articles for article (PubMed ID: 2354484)
61. [Randomized, comparative study to evaluate efficacy and safety of doxazosin versus nitrendipine in the treatment of mild to moderate hypertension].
Sanz Guajardo D; Espejo Martínez J
An Med Interna; 1997 Jan; 14(1):15-9. PubMed ID: 9091027
[TBL] [Abstract][Full Text] [Related]
62. [Effects of i.v. nicardipine in the treatment of hypertensive crisis].
Bolognesi R; Tsialtas D; Straneo U; Conti M; Manca C
Minerva Cardioangiol; 1990 Jun; 38(6):299-303. PubMed ID: 2250772
[TBL] [Abstract][Full Text] [Related]
63. Nitrendipine monotherapy in severe hypertension.
Mroczek WJ; Burris JF
Angiology; 1988 Jan; 39(1 Pt 2):81-6. PubMed ID: 3341610
[TBL] [Abstract][Full Text] [Related]
64. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
Kopf D; Schmitz H; Beyer J; Frank M; Bockisch A; Lehnert H
Diabetes Nutr Metab; 2001 Oct; 14(5):245-52. PubMed ID: 11806464
[TBL] [Abstract][Full Text] [Related]
65. Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension.
Maclean D; Mitchell ET; Lewis R; Irvine N; McLay JS; McEwen J; Coulson RR; Slater ND; Fitzsimons TJ; McDevitt DG
Br J Clin Pharmacol; 1990 Apr; 29(4):455-63. PubMed ID: 2183868
[TBL] [Abstract][Full Text] [Related]
66. Intravenous nicardipine: an effective new agent for the treatment of severe hypertension.
Clifton GG; Wallin JD
Angiology; 1990 Nov; 41(11 Pt 2):1005-9. PubMed ID: 2248422
[TBL] [Abstract][Full Text] [Related]
67. [Controlled comparison of nicardipine and propranolol in the treatment of arterial hypertension].
Kuzmanić A; Rumboldt Z; Naranca M; Bagatin J; Rakić D; Mirić D; Obad M
Lijec Vjesn; 1991; 113(1-2):37-41. PubMed ID: 1890910
[TBL] [Abstract][Full Text] [Related]
68. Evaluation of nitrendipine--a new calcium channel blocker.
Rossouw DS; Luus HG
S Afr Med J; 1991 Apr; 79(7):379-81. PubMed ID: 2014461
[TBL] [Abstract][Full Text] [Related]
69. Hypercholesterolemia modulates the effects of nitrendipine on blood pressure and platelet function in essential hypertension.
Mazeaud MM; Sang KH; Astarie C; Levenson J; Simon A; Devynck MA
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S46-51. PubMed ID: 1725003
[TBL] [Abstract][Full Text] [Related]
70. Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.
Maclean D; Mitchell ET; Laing EM; Macdonald FC; Gough KJ; Dow RJ; McDevitt DG
Br J Clin Pharmacol; 1989 May; 27(5):569-80. PubMed ID: 2667597
[TBL] [Abstract][Full Text] [Related]
71. Long-term antihypertensive effects and safety of nitrendipine in patients with mild, moderate, and severe hypertension.
Kann J
J Clin Pharmacol; 1987 Dec; 27(12):945-50. PubMed ID: 3437066
[TBL] [Abstract][Full Text] [Related]
72. Nicardipine in the treatment of outpatients with cerebrovascular disorders.
Lozano R; Balaguer A
Clin Ther; 1991; 13(4):496-9. PubMed ID: 1934002
[TBL] [Abstract][Full Text] [Related]
73. The effect of slow-release nicardipine on ambulatory and clinic blood pressure in mild hypertension.
Cox JP; Ryan J; O'Brien E; O'Malley K
Br J Clin Pharmacol; 1989 Jul; 28(1):79-82. PubMed ID: 2673316
[TBL] [Abstract][Full Text] [Related]
74. Effects of nicardipine on the metabolic responses to food and exercise.
Ahmed JH; Elliott HL; Hosie J; Farish E; Reid JL
J Hum Hypertens; 1992 Apr; 6(2):139-44. PubMed ID: 1597847
[TBL] [Abstract][Full Text] [Related]
75. [A multicenter study comparing nitrendipine and chlorthalidone in elderly hypertensive patients].
Guillén Llera F; Caballero JC; Guijarro JL; Reuss JM; Rodríguez Mañas L; Sagués F; Sempere R; Tobares N; Vigueras S
Rev Clin Esp; 1990 Sep; 187(4):170-4. PubMed ID: 2091073
[TBL] [Abstract][Full Text] [Related]
76. Chronobiologic evaluation of the efficacy of a new calcium antagonist, nicardipine hydrochloride, in 'essential hypertension'.
Mukaiyama S; Ishii H; Komaya T; Tamura K
Prog Clin Biol Res; 1990; 341A():369-75. PubMed ID: 2217254
[No Abstract] [Full Text] [Related]
77. The use of nitrendipine in the treatment of elderly hypertensives.
Pandita-Gunawardena ND; Macdonald G
Eur Heart J; 1987 Nov; 8 Suppl K():57-62. PubMed ID: 3450522
[TBL] [Abstract][Full Text] [Related]
78. Doxazosin versus nitrendipine: a double-blind comparative study in patients adhering to a sodium-restricted diet.
Cosenzi A; Waltman FL; van Es PN; de Leeuw PW
Cardiovasc Drugs Ther; 1994 Jun; 8(3):473-7. PubMed ID: 7947364
[TBL] [Abstract][Full Text] [Related]
79. Comparison of the efficacy of nicardipine, a new calcium channel blocker, with nifedipine in the treatment of mild to moderate essential hypertension.
Armstrong C; Garnham J; Blackwood R
Postgrad Med J; 1987 Jun; 63(740):463-6. PubMed ID: 3432173
[TBL] [Abstract][Full Text] [Related]
80. Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.
Danielsson A; Bjerle P; Ek B; Steen L; Suhr O
Eur J Clin Pharmacol; 1987; 33(1):15-20. PubMed ID: 3319637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
